TITLE

No Need for the Needle (at First)

AUTHOR(S)
Davidson, Mayer B.
PUB. DATE
October 2008
SOURCE
Diabetes Care;Oct2008, Vol. 31 Issue 10, p2070
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on a study by Chen et al. which describes an approach to the initial treatment of newly diagnosed type 2 diabetic patients with severe hyperglycemia entailing intensive insulin therapy during 10 to 14 days of hospitalization. According to the author, one should carefully examine clinical evidence when deciding on treatments for type 2 diabetes. It is the author's belief that oral antidiabetes drugs (OAD) should be the initial treatment for type 2 diabetes as long as A1c levels of <7.0% can be achieved.
ACCESSION #
35061518

 

Related Articles

  • Safety and Efficacy of Intensive Insulin Therapy in Patients With Thermal Injury. Patel, Mallika P.; Weant, Kyle A.; Ritter, Britt A.; Cairns, Bruce A. // Hospital Pharmacy;Jan2009, Vol. 44 Issue 1, p41 

    Purpose: To evaluate the safety and efficacy of intensive insulin therapy (IIT) versus traditional corrective insulin management (CIM) for the treatment of hyperglycemia in adult patients with thermal injury who are under intensive care. Methods: Using a searchable pharmacy database, a...

  • Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial. Fulcher, Gregory R.; Sandahl Christiansen, Jens; Bantwal, Ganapathi; Polaszewska-Muszynska, Miroslawa; Mersebach, Henriette; Andersen, Thomas H.; Niskanen, Leo K.; Christiansen, Jens Sandahl; BOOST: Intensify Premix I Investigators // Diabetes Care;Aug2014, Vol. 37 Issue 8, p2084 

    Objective: Insulin degludec/insulin aspart (IDegAsp) is the first combination of a basal insulin with an ultralong duration of action, and a rapid-acting insulin in a single injection. This trial compared IDegAsp with biphasic insulin aspart 30 (BIAsp 30) in adults with type 2...

  • American Diabetes Association.  // BioWorld Today;6/29/2010, Vol. 21 Issue 124, p6 

    The article reports on the Phase II results revealed by Halozyme Therapeutics Inc. which demonstrated that the subcutaneous coinjection of recombinant human hyaluronidase, PH20 (rHuPh20) with lispro significantly improves postprandial hyperglycemia, reduced hypoglycemia and accelerates the...

  • Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer. Heinemann, Lutz; Klappoth, W.; Rave, K.; Hompesch, B.; Linkeschowa, R.; Heise, T.; Heinemann, L // Diabetes Care;Sep2000, Vol. 23 Issue 9, p1343 

    Objective: To study the metabolic effect and the variability of the effect elicited by inhalation of 87.2 U insulin powder combined with an absorption enhancer. The metabolic effect was compared with that of 10.2 U regular insulin injected subcutaneously and of 5.5 U regular insulin...

  • Solid dispersion a novel technique for solubility enhancement of poorly water soluble drug gliclazide. Shep, Santosh G.; Vinayak, Mundhe; Shep, Sachin G.; Chandewar, A. V. // Journal of Pharmacy Research;2012, Vol. 5 Issue 3, p1706 

    The aim of this study is to develop a novel sustained-release system for poorly water-soluble drugs by applying solid dispersion technique for improving the solubility. Solubility is an important determinant in drug liberation and absorption and hence plays a key role in its bioavailability. For...

  • Is Exubera Another GlucoWatch?  // Diabetes Health;Apr2006, Vol. 15 Issue 4, p42 

    Relates the opinions of endocrinologists on the potential of Exubera, the noninjectible insulin from Pfizer Inc., to succeed in the U.S. market in 2006. Cost consideration; Possible effect of the drug's absorption issues; Comparison with the Food and Drug Administration approved GlucoWatch...

  • Combinatorial Synthesis and Virtual Screening of Novel Oxazine and Thiazine Mini Libraries for Antidiabetic Activity. More, S. A.; Bhatia, N. M. // Asian Journal of Research in Chemistry;Aug2014, Vol. 7 Issue 8, p751 

    The purpose of the present work was to investigate, following previous works, oxazine and thiazine analogues as antihyperglycemic agent by carrying out docking studies. A series of substituted oxazine and thiazine has been synthesized combinatorially and intermediate compounds were confirmed...

  • METFORMIN.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p542 

    The article presents information on metformin, an antidiabetic drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Antihyperglycemic activity of methanolic extract of Leucas clarkei Hook. sahu, Satyabrata; Swain, Trupti Rekha; Danta, Chhanda Charan // Journal of Pharmacy Research;Oct2010, Vol. 3 Issue 10, p2508 

    An antihyperglycemic activity has been studied by taking the methanolic extract of dried leaves of Lucas clarkei Hook (Lamiaceae). The extraction was done by cold maceration and successive solvent extraction process. This research work was completed in a time period of 14 days by selecting the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics